Skip to content
Study details
Enrolling now

Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy

Massachusetts Institute of Technology
NCT IDNCT05655195ClinicalTrials.gov data as of Apr 2026
Target enrollment

50

Study length

about 3.7 years

Ages

65–100

Locations

1 site in MA

About this study

This trial is testing whether using a light and sound device at home can help people with mild Alzheimer's disease. The device stimulates the brain to boost gamma waves, which may reduce harmful proteins in the brain and improve memory. Participants will use the device daily for 6 months and undergo various tests to measure changes in their brains and cognitive function.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Use GENUS device (Active Settings)
  • 2.Use GENUS device (sham settings)
Primary goalBaseline incidence of stimulation-related adverse symptoms and side effects as assessed by post-stimulation questionnaires

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low9%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Baseline incidence of stimulation-related adverse symptoms and side effects as assessed by post-stimulation questionnaires, Change in stimulation-related adverse symptoms and side effects as assessed by post-stimulation questionnaires, Changes in functional brain connectivity as measured by changes in blood-oxygen-level-dependent (BOLD) signals on functional MRI scans, Changes in functional brain connectivity as measured by changes in brain white matter on functional MRI scans, Endpoint incidence of stimulation-related adverse symptoms and side effects as assessed by post-stimulation questionnaires, Mid-point incidence of stimulation-related adverse symptoms and side effects as assessed by post-stimulation questionnaires

Body systems

Neurology